Esophageal Stricture Clinical Trial
Official title:
Evaluation of Topical Mitomycin C as Adjuvant Drug to Endoscopic Esophageal Dilation in Children
This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal
strictures.
This is a crossover, controlled, clinical trial in which children with esophageal stricture
will be randomized in two groups to receive either topical mitomycin or no additional
treatment during standard esophageal dilation session.
Topical mitomycin C has been used as an adjunct drug to endoscopic treatment of
aero-digestive strictures. There has been some case reports and case series of this
application in esophageal strictures in children, with good results. Nevertheless, it lacks
a controlled clinical trial to access the efficacy of the mitomycin C in this context.
This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal
strictures.
This is a crossover placebo-controlled single-blind clinical trial.
Patients: Subjects up to 18 year-old, with esophageal stricture requiring endoscopic
dilation, either due to dysphagia or by stricture preventing passage of the endoscope.
Inclusion criteria:
- peptic esophageal stricture
- post-surgical esophageal stricture
- caustic esophageal stricture
The patient will be randomized by one treatment group, either A or B.
- A. during the first endoscopic procedure it will be applied of topical mitomycin C over
the esophageal mucosa after dilation, then the second procedure (in two weeks) will be
performed as a standard dilation, without mitomycin C.
- B. the first procedure will be performed in a standard way, and after two weeks, in the
second procedure mytomicin-C will be spread over the esophageal mucosa.
The allocation will not be informed to the patient. At the end of the study protocol, the
patients will be clinically evaluated and the dilation program will continue on discretion
of the assistant doctor. The target esophageal bore is 11 mm (or 12.8 mm if age above 5
yrs).
Mitomycin C will be applied over the esophageal mucosa in the site of stricture after
dilation with a cotton pledget soaked in solution (0.4mg/ml) by three minutes. The pledget
will he held over the mucosa with a biopsy forceps.
Clinical evaluation. Dysphagia will be evaluated by a structured questionnaire, using a
Likert scale. The patient will answer the questionnaire daily.
Main outcome measure: Number of days with improved symptom (dysphagia) after a session.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04372784 -
Cryoablation for Benign Gastrointestinal Anastomotic Strictures
|
N/A | |
Recruiting |
NCT05581173 -
Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
|
||
Terminated |
NCT04406428 -
NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures
|
N/A | |
Completed |
NCT04284826 -
Mitomycin-C Injection Therapy in Refractory Esophageal Stricture
|
N/A | |
Terminated |
NCT03898661 -
Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
|
Early Phase 1 | |
Withdrawn |
NCT04730076 -
Balloon Dilation Methods for Benign Esophageal Stricture
|
N/A | |
Active, not recruiting |
NCT03885310 -
INGEST I Pilot Study
|
N/A | |
Completed |
NCT02069847 -
Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy
|
Phase 2 | |
Completed |
NCT03039608 -
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
|
N/A | |
Terminated |
NCT02354716 -
EndoFLIP Use in Upper GI Tract Stenosis
|
||
Recruiting |
NCT05561114 -
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
|
Phase 3 | |
Not yet recruiting |
NCT04524897 -
The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children
|
Phase 4 | |
Not yet recruiting |
NCT04221867 -
Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)
|
N/A |